(CRS) Carpenter Technology - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1442851036
Stock: Alloys, Titanium, Powder, Stainless, Tool
Total Rating 72
Risk 92
Buy Signal 1.11
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.33% |
| Yield on Cost 5y | 2.49% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 92.2% |
| Payout Ratio | 7.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 49.5% |
| Relative Tail Risk | -9.36% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.44 |
| Alpha | 69.24 |
| Character TTM | |
|---|---|
| Beta | 1.453 |
| Beta Downside | 1.392 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.74% |
| CAGR/Max DD | 3.40 |
Description: CRS Carpenter Technology January 03, 2026
Carpenter Technology Corporation (NYSE: CRS) manufactures, fabricates, and distributes specialty metals-including titanium alloys, powder metals, stainless and alloy steels, and tool steels-through two business segments: Specialty Alloys Operations and Performance Engineered Products. The firm serves a broad customer base across aerospace, defense, medical, transportation, energy, industrial, and consumer markets, operating in North America, Europe, the Asia-Pacific, Mexico, and Canada from its headquarters in Philadelphia.
Key recent metrics indicate FY 2023 revenue of approximately $2.2 billion with an operating margin near 7%, while the aerospace segment, which accounts for roughly 35% of sales, remains sensitive to aircraft production cycles and defense spending trends. Steel and alloy price volatility, driven by global commodity supply constraints and inflationary pressures, continues to impact gross margins, and the company’s ongoing investment in additive-manufacturing capabilities aims to capture growth in high-mix, low-volume aerospace and medical applications.
For a deeper quantitative dive, the ValueRay platform provides a concise, data-rich overview of CRS’s valuation and risk profile.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 434.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 1.35 > 1.0 |
| NWC/Revenue: 45.62% < 20% (prev 41.98%; Δ 3.64% < -1%) |
| CFO/TA 0.14 > 3% & CFO 503.7m > Net Income 434.9m |
| Net Debt (458.2m) to EBITDA (732.4m): 0.63 < 3 |
| Current Ratio: 4.25 > 1.5 & < 3 |
| Outstanding Shares: last quarter (50.3m) vs 12m ago -0.79% < -2% |
| Gross Margin: 28.85% > 18% (prev 0.24%; Δ 2861 % > 0.5%) |
| Asset Turnover: 86.20% > 50% (prev 86.51%; Δ -0.31% > 0%) |
| Interest Coverage Ratio: 11.05 > 6 (EBITDA TTM 732.4m / Interest Expense TTM 53.3m) |
Altman Z'' 6.94
| A: 0.38 (Total Current Assets 1.76b - Total Current Liabilities 412.8m) / Total Assets 3.50b |
| B: 0.55 (Retained Earnings 1.92b / Total Assets 3.50b) |
| C: 0.17 (EBIT TTM 589.2m / Avg Total Assets 3.42b) |
| D: 1.41 (Book Value of Equity 2.14b / Total Liabilities 1.52b) |
| Altman-Z'' Score: 6.94 = AAA |
Beneish M -3.19
| DSRI: 1.04 (Receivables 603.5m/565.4m, Revenue 2.94b/2.88b) |
| GMI: 0.83 (GM 28.85% / 24.02%) |
| AQI: 0.93 (AQ_t 0.10 / AQ_t-1 0.11) |
| SGI: 1.02 (Revenue 2.94b / 2.88b) |
| TATA: -0.02 (NI 434.9m - CFO 503.7m) / TA 3.50b) |
| Beneish M-Score: -3.19 (Cap -4..+1) = AA |
What is the price of CRS shares?
As of February 07, 2026, the stock is trading at USD 365.11 with a total of 1,294,267 shares traded.
Over the past week, the price has changed by +14.88%, over one month by +8.83%, over three months by +15.69% and over the past year by +92.73%.
Over the past week, the price has changed by +14.88%, over one month by +8.83%, over three months by +15.69% and over the past year by +92.73%.
Is CRS a buy, sell or hold?
Carpenter Technology has received a consensus analysts rating of 4.29.
Therefore, it is recommended to buy CRS.
- StrongBuy: 4
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CRS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 384.9 | 5.4% |
| Analysts Target Price | 384.9 | 5.4% |
| ValueRay Target Price | 688.7 | 88.6% |
CRS Fundamental Data Overview February 01, 2026
P/E Trailing = 36.957
P/E Forward = 16.5563
P/S = 5.3812
P/B = 7.9737
P/EG = 1.5913
Revenue TTM = 2.94b USD
EBIT TTM = 589.2m USD
EBITDA TTM = 732.4m USD
Long Term Debt = 690.1m USD (from longTermDebt, last quarter)
Short Term Debt = 8.00m USD (from shortTermDebt, last fiscal year)
Debt = 690.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 458.2m USD (from netDebt column, last quarter)
Enterprise Value = 16.30b USD (15.84b + Debt 690.1m - CCE 231.9m)
Interest Coverage Ratio = 11.05 (Ebit TTM 589.2m / Interest Expense TTM 53.3m)
EV/FCF = 51.47x (Enterprise Value 16.30b / FCF TTM 316.7m)
FCF Yield = 1.94% (FCF TTM 316.7m / Enterprise Value 16.30b)
FCF Margin = 10.76% (FCF TTM 316.7m / Revenue TTM 2.94b)
Net Margin = 14.77% (Net Income TTM 434.9m / Revenue TTM 2.94b)
Gross Margin = 28.85% ((Revenue TTM 2.94b - Cost of Revenue TTM 2.09b) / Revenue TTM)
Gross Margin QoQ = 29.99% (prev 29.49%)
Tobins Q-Ratio = 4.65 (Enterprise Value 16.30b / Total Assets 3.50b)
Interest Expense / Debt = 1.48% (Interest Expense 10.2m / Debt 690.1m)
Taxrate = 19.0% (24.7m / 130.0m)
NOPAT = 477.3m (EBIT 589.2m * (1 - 19.00%))
Current Ratio = 4.25 (Total Current Assets 1.76b / Total Current Liabilities 412.8m)
Debt / Equity = 0.35 (Debt 690.1m / totalStockholderEquity, last quarter 1.99b)
Debt / EBITDA = 0.63 (Net Debt 458.2m / EBITDA 732.4m)
Debt / FCF = 1.45 (Net Debt 458.2m / FCF TTM 316.7m)
Total Stockholder Equity = 1.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.73% (Net Income 434.9m / Total Assets 3.50b)
RoE = 22.99% (Net Income TTM 434.9m / Total Stockholder Equity 1.89b)
RoCE = 22.82% (EBIT 589.2m / Capital Employed (Equity 1.89b + L.T.Debt 690.1m))
RoIC = 18.46% (NOPAT 477.3m / Invested Capital 2.59b)
WACC = 10.85% (E(15.84b)/V(16.53b) * Re(11.27%) + D(690.1m)/V(16.53b) * Rd(1.48%) * (1-Tc(0.19)))
Discount Rate = 11.27% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.10%
[DCF Debug] Terminal Value 72.57% ; FCFF base≈292.3m ; Y1≈360.5m ; Y5≈614.0m
Fair Price DCF = 122.1 (EV 6.54b - Net Debt 458.2m = Equity 6.08b / Shares 49.8m; r=10.85% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 97.03 | EPS CAGR: 137.0% | SUE: 1.03 | # QB: 4
Revenue Correlation: 77.67 | Revenue CAGR: 11.20% | SUE: -0.38 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.59 | Chg30d=+0.043 | Revisions Net=+1 | Analysts=3
EPS current Year (2026-06-30): EPS=10.32 | Chg30d=+0.175 | Revisions Net=+1 | Growth EPS=+37.9% | Growth Revenue=+7.5%
EPS next Year (2027-06-30): EPS=11.35 | Chg30d=+0.014 | Revisions Net=+1 | Growth EPS=+10.0% | Growth Revenue=+10.1%
P/E Forward = 16.5563
P/S = 5.3812
P/B = 7.9737
P/EG = 1.5913
Revenue TTM = 2.94b USD
EBIT TTM = 589.2m USD
EBITDA TTM = 732.4m USD
Long Term Debt = 690.1m USD (from longTermDebt, last quarter)
Short Term Debt = 8.00m USD (from shortTermDebt, last fiscal year)
Debt = 690.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 458.2m USD (from netDebt column, last quarter)
Enterprise Value = 16.30b USD (15.84b + Debt 690.1m - CCE 231.9m)
Interest Coverage Ratio = 11.05 (Ebit TTM 589.2m / Interest Expense TTM 53.3m)
EV/FCF = 51.47x (Enterprise Value 16.30b / FCF TTM 316.7m)
FCF Yield = 1.94% (FCF TTM 316.7m / Enterprise Value 16.30b)
FCF Margin = 10.76% (FCF TTM 316.7m / Revenue TTM 2.94b)
Net Margin = 14.77% (Net Income TTM 434.9m / Revenue TTM 2.94b)
Gross Margin = 28.85% ((Revenue TTM 2.94b - Cost of Revenue TTM 2.09b) / Revenue TTM)
Gross Margin QoQ = 29.99% (prev 29.49%)
Tobins Q-Ratio = 4.65 (Enterprise Value 16.30b / Total Assets 3.50b)
Interest Expense / Debt = 1.48% (Interest Expense 10.2m / Debt 690.1m)
Taxrate = 19.0% (24.7m / 130.0m)
NOPAT = 477.3m (EBIT 589.2m * (1 - 19.00%))
Current Ratio = 4.25 (Total Current Assets 1.76b / Total Current Liabilities 412.8m)
Debt / Equity = 0.35 (Debt 690.1m / totalStockholderEquity, last quarter 1.99b)
Debt / EBITDA = 0.63 (Net Debt 458.2m / EBITDA 732.4m)
Debt / FCF = 1.45 (Net Debt 458.2m / FCF TTM 316.7m)
Total Stockholder Equity = 1.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.73% (Net Income 434.9m / Total Assets 3.50b)
RoE = 22.99% (Net Income TTM 434.9m / Total Stockholder Equity 1.89b)
RoCE = 22.82% (EBIT 589.2m / Capital Employed (Equity 1.89b + L.T.Debt 690.1m))
RoIC = 18.46% (NOPAT 477.3m / Invested Capital 2.59b)
WACC = 10.85% (E(15.84b)/V(16.53b) * Re(11.27%) + D(690.1m)/V(16.53b) * Rd(1.48%) * (1-Tc(0.19)))
Discount Rate = 11.27% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.10%
[DCF Debug] Terminal Value 72.57% ; FCFF base≈292.3m ; Y1≈360.5m ; Y5≈614.0m
Fair Price DCF = 122.1 (EV 6.54b - Net Debt 458.2m = Equity 6.08b / Shares 49.8m; r=10.85% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 97.03 | EPS CAGR: 137.0% | SUE: 1.03 | # QB: 4
Revenue Correlation: 77.67 | Revenue CAGR: 11.20% | SUE: -0.38 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.59 | Chg30d=+0.043 | Revisions Net=+1 | Analysts=3
EPS current Year (2026-06-30): EPS=10.32 | Chg30d=+0.175 | Revisions Net=+1 | Growth EPS=+37.9% | Growth Revenue=+7.5%
EPS next Year (2027-06-30): EPS=11.35 | Chg30d=+0.014 | Revisions Net=+1 | Growth EPS=+10.0% | Growth Revenue=+10.1%